His genes forecast Alzheimer’s. His brain had other plans. (Links to an external site)

Study offers clues to treatment, prevention
Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer’s.
WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise